teduglutide (Gattex)
Jump to navigation
Jump to search
Indications
- treatment of short bowel syndrome
Contraindications
- not for treatment of chronic watery diarrhea after ileal resection in patients with Crohn's disease[4] Dosge:
Injection: 5 mg
Mechanism of action
More general terms
References
- ↑ RxNorm
- ↑ PubChem: 16139605
- ↑ Jeppesen PB Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome Therap Adv Gastroenterol. 2012 May; 5(3): 159-171. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22570676 <Internet> http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342570/
- ↑ 4.0 4.1 NEJM Knowledge+